These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25247439)

  • 41. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
    Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Drug abuse among new draftees].
    Jørgensen HO; Calov E
    Ugeskr Laeger; 1996 Mar; 158(12):1653-6. PubMed ID: 8644406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychoactive drug abuse in older adults.
    Simoni-Wastila L; Yang HK
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of legal highs in the urine of methadone-treated patient by LC-MS.
    Labuz K; Adamowicz P; Kała M; Pyrc K; Reszke E; Mielczarek P; Silberring J; Smoluch M
    Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):253-258. PubMed ID: 31188528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Substance abuse monitoring by the Correctional Service of Canada.
    Fraser AD; Zamecnik J
    Ther Drug Monit; 2002 Feb; 24(1):187-91. PubMed ID: 11805743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urine drug testing results and paired oral fluid comparison from patients enrolled in long-term medication-assisted treatment in Tennessee.
    Miller KL; Puet BL; Roberts A; Hild C; Carter J; Black DL
    J Subst Abuse Treat; 2017 May; 76():36-42. PubMed ID: 28131519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pattern of drugs of abuse identified in chemical samples.
    Dar FJ; Khan AH; Siddiqui I; Ghani F
    J Coll Physicians Surg Pak; 2010 Sep; 20(9):608-11. PubMed ID: 20810054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of anonymized pooled urine in nine UK cities: variation in classical recreational drug, novel psychoactive substance and anabolic steroid use.
    Archer JR; Hudson S; Jackson O; Yamamoto T; Lovett C; Lee HM; Rao S; Hunter L; Dargan PI; Wood DM
    QJM; 2015 Dec; 108(12):929-33. PubMed ID: 25770158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of random and postaccident urine drug tests in southern Indiana coal miners.
    Price JW
    J Addict Med; 2012 Dec; 6(4):253-7. PubMed ID: 22895464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relapse in schizophrenia: is there a relationship to substance abuse?
    Gupta S; Hendricks S; Kenkel AM; Bhatia SC; Haffke EA
    Schizophr Res; 1996 May; 20(1-2):153-6. PubMed ID: 8794503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urine specimen detection of concurrent nonprescribed medicinal and illicit drug use in patients prescribed buprenorphine.
    Guo AY; Ma JD; Best BM; Atayee RS
    J Anal Toxicol; 2013; 37(9):636-41. PubMed ID: 24080973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urine screening for abused drugs in new admissions to a VA hospital.
    McMillan DE; Newton JE; Cannon DJ; Metzer WS; Paige SR; Summers BN; Fody EP
    Br J Addict; 1989 Dec; 84(12):1499-506. PubMed ID: 2611433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
    Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
    Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transitions during effective treatment for cocaine-abusing homeless persons: establishing abstinence, lapse, and relapse, and reestablishing abstinence.
    Milby JB; Schumacher JE; Vuchinich RE; Wallace D; Plant MA; Freedman MJ; McNamara C; Ward CL
    Psychol Addict Behav; 2004 Sep; 18(3):250-6. PubMed ID: 15482080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contingency management: utility in the treatment of drug abuse disorders.
    Stitzer ML; Vandrey R
    Clin Pharmacol Ther; 2008 Apr; 83(4):644-7. PubMed ID: 18305456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: post-intervention outcomes.
    DeFulio A; Silverman K
    Addiction; 2011 May; 106(5):960-7. PubMed ID: 21226886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population.
    West R; Pesce A; West C; Crews B; Mikel C; Almazan P; Rosenthal M; Latyshev S
    Pain Physician; 2010; 13(1):71-8. PubMed ID: 20119465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Underestimation of substance abuse in psychiatric patients by conventional hospital screening.
    Reidy LJ; Junquera P; Van Dijck K; Steele BW; Nemeroff CB
    J Psychiatr Res; 2014 Dec; 59():206-12. PubMed ID: 25262418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study.
    Marquet P; Delpla PA; Kerguelen S; Bremond J; Facy F; Garnier M; Guery B; Lhermitte M; Mathé D; Pelissier AL; Renaudeau C; Vest P; Seguela JP
    J Forensic Sci; 1998 Jul; 43(4):806-11. PubMed ID: 9670503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.